Publications by authors named "Daniel Deon"

Claim this Profile
D
Discovery of Two Novel Antiplatelet Clinical Candidates (BMS-986120 and BMS-986141) That Antagonize Protease-Activated Receptor 4.
E Scott Priestley, Jacques Banville, Daniel Deon, Laurence Dubé, Marc Gagnon

J Med Chem· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dual-Target Inhibitors of the Folate Pathway Inhibit Intrinsically Trimethoprim-Resistant DfrB Dihydrofolate Reductases.
Jacynthe L Toulouse, Genbin Shi, Claudèle Lemay-St-Denis, Maximilian C C J C Ebert, Daniel Deon

ACS Med Chem Lett· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Structure-Based Design of Dimeric Bisbenzimidazole Inhibitors to an Emergent Trimethoprim-Resistant Type II Dihydrofolate Reductase Guides the Design of Monomeric Analogues.
Jacynthe L Toulouse, Brahm J Yachnin, Edward H Ruediger, Daniel Deon, Marc Gagnon

ACS Omega· June 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The effects of NS5A inhibitors on NS5A phosphorylation, polyprotein processing and localization.
Dike Qiu, Julie A Lemm, Donald R O'Boyle, Jin-Hua Sun, Peter T Nower, Daniel H Deon

J Gen Virol· November 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis